HBM Holdings enters strategic biologics R&D collaboration with SinopharmPUBT·Jul 27 at 04:00 AM01099-1.25%02142+4.96%
Sinopharm declares final dividend of RMB 0.69 a share for FY2025PUBT·Jun 18 at 04:05 AM01099-1.25%000028-0.76%
Sinopharm Accord's Wind ESG rating has been upgraded to A, with a comprehensive score of 7.18, leading the ratings in the healthcare providers and services industry同壁财经·Jun 9 at 04:15 AM000028-0.76%
Sinopharm Seeks Shareholder Mandate for Up to 10% H-Share BuybackTip Ranks·May 27 at 05:57 PM600511-0.71%01099-1.25%
CICC Keeps Their Buy Rating on Sinopharm Group Co (SHTDF)Tip Ranks·Apr 28 at 01:58 AM01099-1.25%000028-0.76%
CLSA Raises Sinopharm TP to HKD25, Maintains OutperformAASTOCKS News·Apr 27 at 10:58 PM000028-0.76%01099-1.25%
Sinopharm Sets April Board Meeting to Approve First-Quarter 2026 ResultsTip Ranks·Apr 10 at 04:10 AM000028-0.76%600511-0.71%
Sinopharm Group Co (SHTDF) Gets a Buy from First Shanghai SecuritiesTip Ranks·Apr 5 at 12:16 AM01099-1.25%159849+0.82%
SINOPHARM stated that there are no plans for large-scale store closures this year, as health consumption has become a necessityStheadline·Mar 23 at 01:37 AM600511-0.71%000028-0.76%
Sinopharm Defies Industry Headwinds With 2025 Profit Growth and Retail TurnaroundTip Ranks·Mar 22 at 05:37 PM000028-0.76%600511-0.71%
Sinopharm Proposes Final Cash Dividend of RMB 0.69 per Share for 2025Tip Ranks·Mar 22 at 05:37 PM000028-0.76%010690.00%
SINOPHARM's subsidiary SINOPHARM(CNCM LTD) earned 1.997 billion RMB for the year, a slight decrease of 0.2%AASTOCKS·Mar 19 at 11:04 AM000028-0.76%588250+1.01%
Sinopharm Subsidiary Posts 2025 Revenue Growth Amid Flat Earnings and Stronger Cash FlowTip Ranks·Mar 19 at 09:11 AM000028-0.76%600056-0.52%
Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities | OSRH Stock NewsStockTitan·Mar 18 at 11:55 PM159849+0.82%562600+1.57%
Sinopharm Accord Posts Strong 2025 Profit Growth Despite Slight Revenue DipTip Ranks·Mar 17 at 05:39 PM600511-0.71%200028-0.17%
